Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 6.954M
June 30, 2026 17.59M
March 31, 2026 -135.23M
December 31, 2025 -76.93M
September 30, 2025 6.753M
June 30, 2025 6.678M
March 31, 2025 15.36M
December 31, 2024 11.35M
September 30, 2024 16.14M
June 30, 2024 14.01M
March 31, 2024 10.06M
December 31, 2023 7.741M
September 30, 2023 3.860M
June 30, 2023 -1.152M
March 31, 2023 40.00M
December 31, 2022 -1.655M
September 30, 2022 31.56M
June 30, 2022 -0.1405M
March 31, 2022 -10.03M
December 31, 2021 -91.18M
September 30, 2021 27.51M
June 30, 2021 -5.912M
March 31, 2021 15.47M
December 31, 2020 0.9353M
September 30, 2020 4.588M
Date Value
June 30, 2020 -16.34M
March 31, 2020 -23.63M
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 -0.0098M
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 -0.0026M
June 30, 2017 -0.0022M
March 31, 2017 -0.0202M
December 31, 2016 -0.0024M
September 30, 2016 -0.0248M
June 30, 2016 -0.023M
March 31, 2016 -0.0631M
December 31, 2015 -0.4748M
September 30, 2015 -0.0013M
June 30, 2015 -0.0039M
March 31, 2015 -0.0023M
December 31, 2014 -0.0065M
September 30, 2014 -0.0107M
August 31, 2014
May 31, 2014
February 28, 2014 0.0008M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Talphera, Inc. 12.92M
Journey Medical Corp. 0.00
ANI Pharmaceuticals, Inc. -13.50M
Corcept Therapeutics, Inc. -131.99M
Veru, Inc. 1.802M